In a first time, we will characterize the tissue distribution, the phenotype and the effector functions of NK cells present in the human healthy skin. 12 months [clinicaltrials_resource:702a749ef136761a49cdad12cb5bc525]
Healthy volunteer
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
In a first time, we will characterize the tissue distribution, the phenotype and the effector functions of NK cells present in the human healthy skin. 12 months [clinicaltrials_resource:702a749ef136761a49cdad12cb5bc525]
Healthy volunteer
Bio2RDF identifier
702a749ef136761a49cdad12cb5bc525
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:702a749ef136761a49cdad12cb5bc525
measure [clinicaltrials_vocabulary:measure]
In a first time, we will chara ...... ent in the human healthy skin.
time frame [clinicaltrials_vocabulary:time-frame]
description
Healthy volunteer
identifier
clinicaltrials_resource:702a749ef136761a49cdad12cb5bc525
title
In a first time, we will chara ...... human healthy skin. 12 months
@en
type
label
In a first time, we will chara ...... a749ef136761a49cdad12cb5bc525]
@en